关注
Tom P Freeman
Tom P Freeman
Reader, Addiction and Mental Health Group, Department of Psychology, University of Bath
在 bath.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ...
The Lancet Psychiatry 6 (5), 427-436, 2019
7892019
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
S Chandra, MM Radwan, CG Majumdar, JC Church, TP Freeman, ...
European archives of psychiatry and clinical neuroscience 269, 5-15, 2019
4592019
Keep off the grass? Cannabis, cognition and addiction
HV Curran, TP Freeman, C Mokrysz, DA Lewis, CJA Morgan, LH Parsons
Nature Reviews Neuroscience 17 (5), 293-306, 2016
4572016
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
CJA Morgan, G Schafer, TP Freeman, HV Curran
The British Journal of Psychiatry 197 (4), 285-290, 2010
3962010
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
TP Freeman, AR Winstock
Psychological medicine 45 (15), 3181-3189, 2015
3202015
Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis
CJA Morgan, TP Freeman, GL Schafer, HV Curran
Neuropsychopharmacology 35 (9), 1879-1885, 2010
2602010
Medicinal use of cannabis based products and cannabinoids
TP Freeman, C Hindocha, SF Green, MAP Bloomfield
Bmj 365, 2019
2472019
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
CJA Morgan, C Gardener, G Schafer, S Swan, C Demarchi, TP Freeman, ...
Psychological medicine 42 (2), 391-400, 2012
2422012
The neuropsychopharmacology of cannabis: A review of human imaging studies
MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ...
Pharmacology & therapeutics 195, 132-161, 2019
2312019
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
E Chesney, D Oliver, A Green, S Sovi, J Wilson, A Englund, TP Freeman, ...
Neuropsychopharmacology 45 (11), 1799-1806, 2020
2242020
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
AM Freeman, K Petrilli, R Lees, C Hindocha, C Mokrysz, HV Curran, ...
Neuroscience & Biobehavioral Reviews 107, 696-712, 2019
2092019
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis …
C Hindocha, TP Freeman, G Schafer, C Gardener, RK Das, CJA Morgan, ...
European Neuropsychopharmacology 25 (3), 325-334, 2015
1982015
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
TP Freeman, S Craft, J Wilson, S Stylianou, M ElSohly, M Di Forti, ...
Addiction 116 (5), 1000-1010, 2021
1952021
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
TP Freeman, V Lorenzetti
Addiction 115 (7), 1207-1216, 2020
1722020
Can we make cannabis safer?
A Englund, TP Freeman, RM Murray, P McGuire
The Lancet Psychiatry 4 (8), 643-648, 2017
1722017
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
TP Freeman, C Hindocha, G Baio, NDC Shaban, EM Thomas, D Astbury, ...
The Lancet Psychiatry 7 (10), 865-874, 2020
1682020
No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit
C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock
Frontiers in psychiatry 7, 184619, 2016
1622016
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
TP Freeman, CJA Morgan, C Hindocha, G Schafer, RK Das, HV Curran
Addiction 109 (10), 1686-1694, 2014
1572014
Increasing potency and price of cannabis in Europe, 2006–16
TP Freeman, T Groshkova, A Cunningham, R Sedefov, P Griffiths, ...
Addiction 114 (6), 1015-1023, 2019
1532019
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
CJA Morgan, TP Freeman, C Hindocha, G Schafer, C Gardner, HV Curran
Translational psychiatry 8 (1), 181, 2018
1522018
系统目前无法执行此操作,请稍后再试。
文章 1–20